(CPT) Camden Property Trust - Overview
Sector: Real Estate | Industry: REIT - Residential | Exchange: NYSE (USA) | Market Cap: 10.397m USD | Total Return: -9.5% in 12m
Industry Rotation: +3.8
Avg Turnover: 111M
EPS Trend: -56.0%
Qual. Beats: -1
Rev. Trend: 82.5%
Qual. Beats: 0
Warnings
Altman Z'' -1.01 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Camden Property Trust (CPT) is an S&P 500 real estate investment trust specializing in the full lifecycle of multifamily apartment communities, including development, construction, and management. Headquartered in Texas, the firm maintains a geographically diverse portfolio of 172 properties totaling over 58,000 apartment homes across the United States. The company currently has three additional projects under development to expand its total unit count.
Operating as a residential REIT, Camden generates revenue primarily through long-term lease agreements, benefiting from the consistent demand for rental housing in high-growth urban and suburban markets. This business model typically offers a hedge against inflation, as multifamily leases are frequently reset to reflect current market rates. Investors can find further data regarding CPTs historical performance and valuation metrics on ValueRay.
- Sun Belt migration patterns dictate occupancy levels and organic rent growth
- Elevated interest rates increase development financing costs and cap rate expansion
- High supply of new apartment deliveries pressures net effective rental rates
- Employment growth in diversified markets sustains consistent cash flow and dividends
- Operating margin fluctuations driven by property tax assessments and insurance premiums
| Net Income: 388.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.20 > 1.0 |
| NWC/Revenue: -71.93% < 20% (prev -20.02%; Δ -51.90% < -1%) |
| CFO/TA 0.09 > 3% & CFO 826.5m > Net Income 388.1m |
| Net Debt (4.14b) to EBITDA (1.16b): 3.58 < 3 |
| Current Ratio: 0.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (104.9m) vs 12m ago -3.41% < -2% |
| Gross Margin: 42.29% > 18% (prev 0.61%; Δ 4.17k% > 0.5%) |
| Asset Turnover: 17.44% > 50% (prev 17.25%; Δ 0.19% > 0%) |
| Interest Coverage Ratio: 3.85 > 6 (EBITDA TTM 1.16b / Interest Expense TTM 141.5m) |
| A: -0.12 (Total Current Assets 138.4m - Total Current Liabilities 1.27b) / Total Assets 9.06b |
| B: -0.11 (Retained Earnings -1.04b / Total Assets 9.06b) |
| C: 0.06 (EBIT TTM 544.4m / Avg Total Assets 9.03b) |
| D: -0.21 (Book Value of Equity -1.03b / Total Liabilities 4.95b) |
| Altman-Z'' Score: -1.01 = CCC |
| DSRI: 0.89 (Receivables 8.08m/8.95m, Revenue 1.57b/1.55b) |
| GMI: 1.45 (GM 42.29% / 61.26%) |
| AQI: 0.85 (AQ_t 0.02 / AQ_t-1 0.03) |
| SGI: 1.01 (Revenue 1.57b / 1.55b) |
| TATA: -0.05 (NI 388.1m - CFO 826.5m) / TA 9.06b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
Over the past week, the price has changed by -1.14%, over one month by +1.19%, over three months by -4.30% and over the past year by -9.50%.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 113.8 | 10.9% |
P/E Forward = 69.4444
P/S = 6.5599
P/B = 2.5522
P/EG = 9.1681
Revenue TTM = 1.57b USD
EBIT TTM = 544.4m USD
EBITDA TTM = 1.16b USD
Long Term Debt = 4.25b USD (from longTermDebt, last quarter)
Short Term Debt = 1.27b USD (from shortTermDebt, last quarter)
Debt = 4.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.14b USD (from netDebt column, last quarter)
Enterprise Value = 14.54b USD (10.40b + Debt 4.28b - CCE 130.3m)
Interest Coverage Ratio = 3.85 (Ebit TTM 544.4m / Interest Expense TTM 141.5m)
EV/FCF = 20.37x (Enterprise Value 14.54b / FCF TTM 714.0m)
FCF Yield = 4.91% (FCF TTM 714.0m / Enterprise Value 14.54b)
FCF Margin = 45.37% (FCF TTM 714.0m / Revenue TTM 1.57b)
Net Margin = 24.66% (Net Income TTM 388.1m / Revenue TTM 1.57b)
Gross Margin = 42.29% ((Revenue TTM 1.57b - Cost of Revenue TTM 908.2m) / Revenue TTM)
Gross Margin QoQ = -15.38% (prev 62.20%)
Tobins Q-Ratio = 1.61 (Enterprise Value 14.54b / Total Assets 9.06b)
Interest Expense / Debt = 0.87% (Interest Expense 37.1m / Debt 4.28b)
Taxrate = 2.07% (938k / 45.3m)
NOPAT = 533.1m (EBIT 544.4m * (1 - 2.07%))
Current Ratio = 0.11 (Total Current Assets 138.4m / Total Current Liabilities 1.27b)
Debt / Equity = 1.06 (Debt 4.28b / totalStockholderEquity, last quarter 4.03b)
Debt / EBITDA = 3.58 (Net Debt 4.14b / EBITDA 1.16b)
Debt / FCF = 5.80 (Net Debt 4.14b / FCF TTM 714.0m)
Total Stockholder Equity = 4.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.30% (Net Income 388.1m / Total Assets 9.06b)
RoE = 8.86% (Net Income TTM 388.1m / Total Stockholder Equity 4.38b)
RoCE = 6.31% (EBIT 544.4m / Capital Employed (Equity 4.38b + L.T.Debt 4.25b))
RoIC = 6.42% (NOPAT 533.1m / Invested Capital 8.31b)
WACC = 4.87% (E(10.40b)/V(14.67b) * Re(6.52%) + D(4.28b)/V(14.67b) * Rd(0.87%) * (1-Tc(0.02)))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -1.68%
[DCF] Terminal Value 88.36% ; FCFF base≈596.9m ; Y1≈729.8m ; Y5≈1.22b
[DCF] Fair Price = 315.6 (EV 35.42b - Net Debt 4.14b = Equity 31.27b / Shares 99.1m; r=6.0% [WACC]; 5y FCF grow 23.81% → 3.0% )
EPS Correlation: -56.03 | EPS CAGR: -72.36% | SUE: -4.0 | # QB: -1
Revenue Correlation: 82.49 | Revenue CAGR: 2.09% | SUE: 0.07 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.22 | Chg30d=-18.52% | Revisions=N/A | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.17 | Chg30d=-69.72% | Revisions=N/A | Analysts=2
EPS current Year (2026-12-31): EPS=0.72 | Chg30d=-34.48% | Revisions=N/A | GrowthEPS=-43.8% | GrowthRev=-0.5%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=-12.10% | Revisions=-20% | GrowthEPS=+73.8% | GrowthRev=+2.6%
[Analyst] Revisions Ratio: -20%